Full Press Release Details
Nurix Therapeutics Appoints Anil Kapur to its Board of Directors.
NRIX
Nurix Therapeutics Appoints Anil Kapur to its Board of Directors
Key Takeaway: Nurix Therapeutics Appoints Anil Kapur to its Board of Directors
Price reaction · baseline $24.87 (2024-10-15 close) · hit after-hours · 3 other NRIX headline(s) in the window, move may be shared
day 0 close · peak
+3.8%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+85%
120-day peak, hindsight
Typical move
4.4%
average across 9 past catalysts
Cash runway
~14 mo
Low dilution risk
Lead asset
NX-5948
Phase 3 · B-cell Lymphoma